Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
about
Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal CancerRadiation therapy and esophageal cancerSparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy.Current strategies in chemoradiation for esophageal cancer.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature.An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.Proton therapy radiation pneumonitis local dose-response in esophagus cancer patientsAccelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?Predictors of postoperative complications after trimodality therapy for esophageal cancer.Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer.Proton beam therapy and concurrent chemotherapy for esophageal cancer.Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.Cardiac toxicity in the radiation treatment of esophageal cancer: an emerging concern.Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort.Proton radiotherapy dose perturbations caused by esophageal stents of varying material composition are negligible in an experimental model.Update: modern approaches to the treatment of localized esophageal cancer.The utility of proton beam therapy with concurrent chemotherapy for the treatment of esophageal cancers.Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience.Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.Proton therapy for esophageal cancer.Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy.Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy.Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer.Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
P2860
Q26753864-8548F92E-4BEF-413A-B160-152D91345519Q27026922-C400CC30-03C3-4C55-8F67-89DF8E9516F1Q33276446-EF783E4D-F094-403B-A9CD-F5EC25D7D78AQ33820782-6D8EE685-9771-4708-B265-1B767A0847F2Q34479911-A6A28FA2-A6A8-4A2D-8254-772014EC8CDAQ36322389-BE0233E9-27ED-4616-82FC-6DF0F719720AQ36818873-CF3C1521-B7E9-4EE0-B24C-46A9875B55FEQ36968104-CDDE851F-B000-43FF-8724-B778BDC97E87Q37127147-CD860670-C9AC-4F65-B86D-793983727C4DQ37205342-605772AD-1559-4955-8B35-3E76D6E54106Q37414605-0CF890D1-54CA-47C2-A769-6364D5041778Q37582515-E914FA8B-455B-44B4-9E43-B88ABAFA6D1BQ38683954-CFD1168D-8A6B-4E62-8BF7-FC879704EB48Q38937672-600FE2B6-CD43-466E-85F9-0B0A357CC5AEQ38978080-B1035464-7838-49F6-AB71-70C6E484FFA3Q39376002-B9C748C3-0186-4578-991A-B77E46D8C7E8Q40389418-8A6F9D4D-564A-4E4E-9B88-3831EC6EE7E6Q42011346-5D8E8E8B-15F3-41EE-A30F-2C1E2E3256AFQ42585530-85D9AA7A-624E-447C-A9E2-14519C6A603CQ43379663-DF8D1F14-B501-4BCF-B0C2-65C7ECE987B3Q47142302-44257816-F435-442F-BBBC-3C6FFBE6C68EQ50050320-86D713FC-8B82-4B2C-9071-0893ED6BC56EQ50052519-38C5EB69-A0CD-4CE5-B92D-CAA9A3642A74Q53158357-4BA58153-4383-4E8B-9FB4-C68127272238Q54652098-4D80ED91-A130-4101-97C0-65D2C6918065Q55020408-A7BB7795-CB70-4589-9793-3CA74A95E426Q55373951-9F14C692-42A7-4C42-B94D-5D4CD012732D
P2860
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@en
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@nl
type
label
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@en
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@nl
prefLabel
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@en
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@nl
P2093
P2860
P1476
Intensity-modulated proton the ...... al tumors: a dosimetric study.
@en
P2093
Amin V Mayankkumar
Anna Likhacheva
Beverly A Riley
Daniel Gomez
Jaffer A Ajani
James D Cox
James Welsh
Matthew B Palmer
Wayne L Hofstetter
X Ronald Zhu
P2860
P304
P356
10.1016/J.IJROBP.2010.07.2001
P407
P577
2011-04-04T00:00:00Z